Patents by Inventor Chris David Edlin

Chris David Edlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE
    Publication number: 20250249023
    Abstract: This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an ?-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
    Type: Application
    Filed: April 23, 2025
    Publication date: August 7, 2025
    Inventors: Brian Paul O'NEILL, Hardik Kirtikumar SHAH, Julian Alexander BLAIR, Chris David EDLIN, Shane Michael MCKEON
  • Inhalable formulation of fluticasone propionate and albuterol sulfate
    Patent number: 12310979
    Abstract: This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an ?-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
    Type: Grant
    Filed: April 25, 2023
    Date of Patent: May 27, 2025
    Assignee: NORTON (WATERFORD) LIMITED
    Inventors: Brian Paul O′Neill, Hardik Kirtikumar Shah, Julian Alexander Blair, Chris David Edlin, Shane Michael McKeon
  • AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE
    Publication number: 20240033222
    Abstract: This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an ?-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
    Type: Application
    Filed: August 16, 2021
    Publication date: February 1, 2024
    Applicant: NORTON (WATERFORD) LIMITED
    Inventors: Brian Paul O'NEILL, Hardik Kirtikumar SHAH, Julian Alexander BLAIR, Chris David EDLIN, Shane Michael MCKEON
  • INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE
    Publication number: 20230255983
    Abstract: This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an ?-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
    Type: Application
    Filed: April 25, 2023
    Publication date: August 17, 2023
    Inventors: Brian Paul O'Neill, Hardik Kirtikumar Shah, Julian Alexander Blair, Chris David Edlin, Shane Michael McKeon
  • Inhalable formulation of fluticasone propionate and albuterol sulfate
    Patent number: 11638710
    Abstract: This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an ?-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
    Type: Grant
    Filed: August 24, 2021
    Date of Patent: May 2, 2023
    Assignee: NORTON (WATERFORD) LIMITED
    Inventors: Brian Paul O'Neill, Hardik Kirtikumar Shah, Julian Alexander Blair, Chris David Edlin, Shane Michael McKeon
  • Inhalable Formulation of Fluticasone Propionate and Albuterol Sulfate
    Publication number: 20220047610
    Abstract: This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an ?-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
    Type: Application
    Filed: August 24, 2021
    Publication date: February 17, 2022
    Applicant: Norton (Waterford) Limited
    Inventors: Brian Paul O'Neill, Hardik Kirtikumar Shah, Julian Alexander Blair, Chris David Edlin, Shane Michael McKeon